The thickness of cortical brain tissue progressively reduces as individuals develop psychosis, according to researchers of a large, multi-site study of young adults at clinical high risk. Onset of psychosis typically occurs during the transition from adolescence to early adulthood, a period of time when the brain is also maturing. Brain tissue is commonly divided by its appearance on magnetic resonance imaging (MRI) into gray matter, the component of cortical tissue containing nerve cell bodies, and white matter, the component of cortical tissue containing the axons or projections from these nerve cell bodies.
Prior neuroimaging research has established that individuals who convert to psychosis have more rapid and more pronounced gray matter loss, compared to non-converters and healthy individuals. However, since the long-term effects of antipsychotic medications on cortical gray matter are not well understood and nearly all patients are treated with these medications, it has been difficult to distinguish the effects of antipsychotic drug treatment from the progression of schizophrenia.
Researchers from Yale University currently running the North American Prodrome Longitudinal Study Consortium have now provided important new insights into cortical changes associated with the development of psychosis.
They conducted a longitudinal MRI study across 8 U.S. sites. They recruited 274 individuals at clinical high risk for psychosis and 135 healthy controls. Each participant received an initial (baseline) scan and a second scan either one year later or at the time of conversion to psychosis.
Thirty-five individuals ultimately converted to psychosis and they showed a steeper rate of thinning in prefrontal cortex compared with those who did not convert and the healthy control group. Importantly, this tissue loss was not explained by exposure to antipsychotic drugs. Because this differential rate of tissue loss was observed among subjects who had never been exposed to psychiatric drugs, the medical community can now conclude that the brain changes are part of the natural course of the disorder rather than being a consequence of treatment.
Interestingly, the tissue loss observed in the converters was correlated with levels of proinflammatory cytokines in plasma, suggesting the presence of systemic neuroinflammation.
The team state that the findings are also important in showing that markers of proinflammatory cytokines at the baseline assessment predicted the rate of gray matter loss among the individuals who converted to psychosis, suggesting that activation of microglia was involved in the tissue loss.
This could mean that psychosis is associated with an abnormal acceleration in the processes underlying normal synaptic pruning during late adolescence/early adulthood, or that some kind of immune-related process is involved in psychosis onset, or both.
Experts state that inflammation is increasingly recognized as a contributing factor to the emergence of progression of disease in every organ in the body adding that this report suggests that neuroinflammation may be a process that in some cases moves patients from the at-risk state into psychosis.
The team recommends that future work be conducted to evaluate whether inflammation precedes and perhaps even predicts such gray matter loss, or whether it is a consequence of such loss.
Source: Reed Elsevier Group PLC
antipsychotic, healthinnovations, immune response, immunology, Interleukin, magnetic resonance imaging, microglia, neurobiology, neuroimaging, neuroinflammation, neuroinnovations, psychosis, schizophrenia
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.